Publications by authors named "Yang-Li Zhang"
Article Synopsis
- Lung salivary-type tumors, particularly oncocytic carcinoma, are rare, with specific classifications outlined by the WHO, and this report details a unique case found in a 34-year-old male.
- The patient presented with hemoptysis and dyspnea, and after various tests including CT scans and biopsies, a polypiform nodule was diagnosed and successfully resected, revealing tumor characteristics.
- Follow-up after surgery showed no recurrence, highlighting the importance of diagnosis and appropriate intervention in these rare tumors.
[Prokaryotic expression, purification and identification of recombinant staphylokinase-HC fusion protein].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
November 2012
Aim: To construct the prokaryotic expression plasmid pEGX-6P-1-SAK-HC, express it in E.coli, and identify its biological activity.
Methods: The fusion gene (SAK-HC) was obtained by overlap-extension PCR and then inserted into prokaryotic soluble pEGX-6P-1 vector with GST tag to construct expression plasmid (pEGX-6P-1-SAK-HC).
[Predictive study of HBsAg in different stages of neonatal venous blood on failure of blocking HBV mother to infant transmission].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
October 2011
Objective: In this study, we discuss the predictive value of different content of HBsAg in different stages of neotal venous blood on failure of blocking mother to infant transmission of HBV.
Methods: 150 infants born of chronically HBV infected mothers who were positive of both HBsAg and HBeAg and who also had a HBV DNA virus load above 10(5) copies/ml were enrolled. These infants were given hepatitis B virus immune globin (HBIG) 200 IU immediately after birth and were given hepatitis B vaccine 10 or 20 microg at brith, 1 month and 6 months after birth.
Objective: To compare the efficacy of all-trans retinoic acid (ATRA) combining chemotherapy and As4S4 with ATRA combining chemotherapy for the maintenance treatment of patients with acute promyelocytic leukemia (APL).
Methods: Sixty patients with APL induced to complete remission by ATRA and consolidated by chemotherapy were randomly divided into two groups. Thirty patients as As4S4 group received ATRA + As4S4 + chemotherapy, and another thirty patients as non-As4S4 group were treated only with ATRA + chemotherapy as maintenance therapy.